The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference in Durban, South Africa heard last month.
The world’s largest drug consumption facility has opened in Copenhagen, Denmark, giving people who use drugs a safe place to use illicit substances in a way that will limit harm to themselves, and to those around them.
Heightened concerns regarding the link between the hormonal contraceptive, Depo-Provera, and the risk of HIV acquisition in women after new systematic review released.
Meaningful inclusion of young people is key to effective HIV programming, says Lehlohonolo Mohasoa. And young people are our greatest hope in ending AIDS.
AVERT Chief Executive, Sarah Hand, reflects on the biannual International AIDS Conference (AIDS 2016) in Durban, and where we should focus our efforts for an effective HIV response going forward.
The UK High Court has today ruled that the National Health Service (NHS) England can legally provide the game-changing HIV prevention drug, Truvada, as a pre-exposure prophylaxis (PrEP) to HIV negative people most at risk of HIV – but only if it chooses to.
Prevalence of hepatitis C (HCV) among people who inject drugs in Europe is very high – in excess of 50% across six countries in the region and an estimated 84% in Portugal. But a new report released by EU drug body for World Hepatitis Day (July 28), shows that a combination of new treatments and prevention interventions gives significant reason for optimism in curbing the HCV epidemic among drug users in the region.
A bold new framework, part of the ‘Start Free, Stay Free, AIDS Free’ initiative, was launched at AIDS 2016 with the aim of ending AIDS among children, adolescents and young women by 2020.
The 90-90-90 Fast-Track targets is a hot-topic at this week’s 21st International AIDS Conference in Durban, South Africa (AIDS 2016). Progress towards the targets, which call for 90% of people living with HIV to know their status, 90% on HIV treatment, and 90% virally suppressed, is acheivable but success is not uniform.